Search research articles
Contact Us
Filters
Showing results (411-420 of 567) with videos related to
Page
of 57
Sort By:
Food Microbiology
|
November 28, 2016
MRSA and multidrug-resistant Staphylococcus aureus in U.S. retail meats, 2010-2011
Beilei Ge, Sampa Mukherjee, Chih-Hao Hsu, et al.
Journal for Immunotherapy of Cancer
|
December 20, 2017
Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIM<sup>SM</sup> registry
Brendan Curti, Gregory A Daniels, David F McDermott, et al.
Plos One
|
January 5, 2011
Horizontal gene transfer of a ColV plasmid has resulted in a dominant avian clonal type of Salmonella enterica serovar Kentucky
Timothy J Johnson, Jessica L Thorsness, Cole P Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2011
BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma
Kevin B Kim, Jeffrey A Sosman, John P Fruehauf, et al.
Genome Biology and Evolution
|
April 16, 2014
Comparative genomic analysis and virulence differences in closely related salmonella enterica serotype heidelberg isolates from humans, retail meats, and animals
Maria Hoffmann, Shaohua Zhao, James Pettengill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2016
Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study
David F McDermott, Jeffrey A Sosman, Mario Sznol, et al.
Melanoma Research
|
September 14, 2018
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma
Shalin Shah, Jason J Luke, Heather A Jacene, et al.
BJU International
|
January 20, 2011
Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis
Debra Josephs, Thomas E Hutson, Charles L Cowey, et al.
The Lancet. Oncology
|
February 15, 2018
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
Michael B Atkins, Elizabeth R Plimack, Igor Puzanov, et al.
Journal of Applied Microbiology
|
November 29, 2014
Characterization of antibiotic and disinfectant susceptibility profiles among Pseudomonas aeruginosa veterinary isolates recovered during 1994-2003
R C Beier, S L Foley, M K Davidson, et al.
Page
of 57
Search research articles
Search
Showing results (411-420 of 567) with videos related to
Sort By:
Page
of 57
Food Microbiology
|
November 28, 2016
MRSA and multidrug-resistant Staphylococcus aureus in U.S. retail meats, 2010-2011
Beilei Ge, Sampa Mukherjee, Chih-Hao Hsu, et al.
Journal for Immunotherapy of Cancer
|
December 20, 2017
Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIM<sup>SM</sup> registry
Brendan Curti, Gregory A Daniels, David F McDermott, et al.
Plos One
|
January 5, 2011
Horizontal gene transfer of a ColV plasmid has resulted in a dominant avian clonal type of Salmonella enterica serovar Kentucky
Timothy J Johnson, Jessica L Thorsness, Cole P Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2011
BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma
Kevin B Kim, Jeffrey A Sosman, John P Fruehauf, et al.
Genome Biology and Evolution
|
April 16, 2014
Comparative genomic analysis and virulence differences in closely related salmonella enterica serotype heidelberg isolates from humans, retail meats, and animals
Maria Hoffmann, Shaohua Zhao, James Pettengill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2016
Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study
David F McDermott, Jeffrey A Sosman, Mario Sznol, et al.
Melanoma Research
|
September 14, 2018
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma
Shalin Shah, Jason J Luke, Heather A Jacene, et al.
BJU International
|
January 20, 2011
Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis
Debra Josephs, Thomas E Hutson, Charles L Cowey, et al.
The Lancet. Oncology
|
February 15, 2018
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
Michael B Atkins, Elizabeth R Plimack, Igor Puzanov, et al.
Journal of Applied Microbiology
|
November 29, 2014
Characterization of antibiotic and disinfectant susceptibility profiles among Pseudomonas aeruginosa veterinary isolates recovered during 1994-2003
R C Beier, S L Foley, M K Davidson, et al.
Page
of 57